| Abstrakt: |
A patent application from the University of California discusses the development of proteoglycan mimetics to improve wound healing, angiogenesis, and vascular repair. The application focuses on addressing the need for better treatments for chronic wounds, such as diabetic foot ulcers, as well as complications from coronary artery disease and percutaneous coronary intervention procedures. The inventors propose a compound made up of synthetic peptides that bind to collagen and integrin proteins, linked to a glycan. This compound aims to promote tissue repair and angiogenesis while minimizing the risks associated with current therapies. The research has potential applications in wound healing, angiogenesis, and vascular repair. [Extracted from the article] |
